Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA ‑374a/forkhead box O1 signaling axis.

In conclusion, propofol downregulated miR‑374a and modulated the FOXO1 pathway to reduce proliferation and DDP resistance in ovarian cancer cells. PMID: 32016462 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research